{
    "nctId": "NCT03333226",
    "briefTitle": "Axillary Reverse Mapping (ARM) in Breast Cancer Surgery to Prevent Lymphedema. (ARMtrial)",
    "officialTitle": "Axillary Reverse Mapping (ARM). Identification of the Arm Lymphatic Pathways in Breast Cancer Surgery to Prevent Breast Cancer Related Lymphedema (BCRL): a Randomized Clinical Trial.",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer Lymphedema",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "Incidence of Breast Cancer Related Lymphedema (BCRL) after Axillary Lymph Node Dissection (ALND)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* T1-T2 stage breast cancer\n\nExclusion Criteria:\n\n* axillary lymph node metastasis;\n* previous surgery on the ipsilateral axilla;\n* neoadjuvant chemo-radiotherapy;\n* presence of primitive lymphedema of the arm;\n* allergy to Iodine, thyroid disease, renal and hepatic impairment (for issues related to Indocyanine Green)\n* pregnancy;\n* patients refusing to participate in the study.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}